Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-27
DOI
10.1038/s41598-017-07005-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
- (2016) Hui Zhang et al. CELL
- Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway
- (2016) L Fabris et al. ONCOGENE
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- p27kip1controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability
- (2015) Linda Fabris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
- (2015) Roland F. Schwarz et al. PLOS MEDICINE
- DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance
- (2015) Euan A. Stronach et al. NEOPLASIA
- Genetic characterization of p27kip1and stathmin in controlling cell proliferation in vivo
- (2014) Stefania Berton et al. CELL CYCLE
- Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
- (2014) T. Z. Tan et al. EMBO Molecular Medicine
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
- (2014) Q H Miow et al. ONCOGENE
- Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
- (2014) Corine M. Beaufort et al. PLoS One
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition
- (2013) Benoît Thibault et al. CANCER AND METASTASIS REVIEWS
- Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: Focus on trabectedin
- (2013) Andrés Poveda et al. CANCER TREATMENT REVIEWS
- Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
- (2013) Maura Sonego et al. EMBO Molecular Medicine
- Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
- (2013) Michael S. Anglesio et al. PLoS One
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination
- (2012) Christopher Korch et al. GYNECOLOGIC ONCOLOGY
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer
- (2011) E. A. Stronach et al. CANCER RESEARCH
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
- (2010) N. Ahmed et al. CURRENT CANCER DRUG TARGETS
- Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells
- (2010) B. G. Blair et al. MOLECULAR PHARMACOLOGY
- Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis
- (2009) Lan Dai et al. ELECTROPHORESIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now